Loading clinical trials...
Loading clinical trials...
This study aims to compare the efficacy and safety of fluorescein angiography using 1mL versus 3mL of 10% fluorescein dye.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Seoul National University Bundang Hospital
NCT06789445 · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), and more
NCT06380075 · Retinal Disease
NCT03713268 · Macular Holes, Epiretinal Membrane, and more
NCT06305416 · Diabetic Macular Edema, Diabetic Retinopathy, and more
NCT06520410 · Retinopathy of Prematurity Both Eyes, Retinal Disease, and more
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions